A new Ebola vaccine trial is set to start in the Democratic Republic of the Congo (DR Congo), as health officials warn that infections are spreading faster than expected. The move comes amid figures from the World Health Organization (WHO) indicating a recent acceleration in deaths.
According to the WHO, about half of the roughly 2,500 recorded Ebola deaths occur within the most recent 20 days. Outlets reporting on the development focus on the implications of this speed for public health response, including how quickly vaccination and other measures must reach affected communities.
While the coverage agrees on the timeline for the trial and the WHO’s warning about the pace of transmission and fatalities, the outlets emphasize different aspects: one highlights the start of the trial itself, while another stresses the urgency created by the concentration of deaths in a short period. Both frames point to the same underlying concern—rapid spread during the ongoing outbreak.
